Treatment of resistant pain in hypertrophic pulmonary osteoarthropathy with subcutaneous octreotide.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 9093354.
- Also identified by PMC identifier 1758508.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pain in hypertrophic pulmonary osteoarthropathy (HPOA) due to periostitis and arthropathy can be a particularly disabling symptom, and resistant to a wide variety of treatments. The effectiveness of subcutaneous octreotide in relieving this pain in a patient with HPOA is reported.
Medical subject headings
- Hormones
- Octreotide
- Osteoarthropathy, Secondary Hypertrophic